TTRX
Turn Therapeutics Inc
NASDAQ · Pharmaceuticals
$3.85
+0.15 (+4.05%)
TTRX News5 articles
Linde Shares Face Pressure After JPMorgan Downgrade, Focus Turns to Pricing Outlook
Linde stock fell 2.53% to $448.07 Friday after JPMorgan cut its rating to Neutral, citing valuation and flat sequential pricing. Investors await U.S. jobs data and company conferences this week.
JPMorgan Surges 4% as Dow Breaks 50,000 Milestone; Focus Turns to Economic Data
JPMorgan Chase shares climbed nearly 4% on Friday, closing at $322.40, as the Dow Jones Industrial Average surpassed 50,000 for the first time. Investors now await key U.S. employment and inflation reports this week.
Vodafone Launches Share Buyback Amid Focus on German Market Turnaround
Vodafone has initiated a £29.4 million share repurchase program while investors monitor Germany's service revenue growth. The telecom giant reported 5.4% group service revenue expansion in Q3.
Westpac Shares Dip Amid ASX Selloff, Focus Turns to Quarterly Update
Westpac shares fell 1.2% as the ASX 200 dropped 2%, erasing A$70 billion. Investors await the bank's Feb. 13 update for margin and credit quality signals following the RBA rate hike.
Verizon's Rally Halts Amid Leadership Shift, Focus Turns to Economic Data
Verizon shares dropped 1.7% on Friday, ending a seven-day advance. The decline followed a management change in its consumer division, with investors now eyeing upcoming U.S. jobs and inflation reports.